Hicks Derek 4
4 · Intellia Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Hicks Derek
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2024-01-03$29.46/sh−3,877$114,216→ 36,987 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2024, and does not represent a volitional trade by the Reporting Person.